Author Archive: AZBio
City of Hope, TGen awarded five-year, $4.5 million grant to advance liquid biopsy for pancreatic cancer
- City of Hope-led consortium seeks to validate noninvasive screening test for pancreatic ductal adenocarcinoma through large-scale cohort
- Inclusion of diverse populations is crucial for advancing understanding of these diseases, promoting health equity, and ensuring that medical research and treatments are inclusive and effective for all populations
Biden-Harris Administration Awards Planning Grant to Accelerate AI and Machine Learning for Medical Device Manufacturing in Phoenix, Arizona
As part of the President’s Investing in America agenda, the U.S. Department of Commerce leverages Tech Hubs Program to spur regional innovation and job creation.Continue reading
ASU announces future medical school to be located in downtown Phoenix
Arizona State University President Michael M. Crow, joined by Phoenix Mayor Kate Gallego, today announced that the university’s headquarters for ASU Health, which includes a new medical school, will be built at a location to be determined in downtown Phoenix.Continue reading
HonorHealth Research Institute, City of Hope and TGen lead international team in creating ‘robust’ early-detection method for pancreatic cancer
SCOTTSDALE, Ariz. — Oct. 18, 2023 — In a significant breakthrough that could eventually extend the survival of patients with one of the deadliest of all malignancies, an international team of researchers have devised an investigational blood test that might one day help doctors detect pancreatic cancer earlier.Continue reading
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
ROOT, Switzerland–Oct 12, 2023 (BUSINESS WIRE)– Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program. The program is intended to support both preclinical studies and clinical trials with TTFields, electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.Continue reading
UArizona Startup NeuTherapeutics Wins $2.5M Grant to Fund Clinical Trial of PhytoSERM, a Natural Approach to Menopausal Hot Flashes
TUCSON, Ariz. – NeuTherapeutics, a Tucson startup founded to commercialize University of Arizona technology has received a $2.5M Small Business Innovation Research (SBIR) grant from the National Institutes of Health/ National Institute on Aging (NIA) to conduct a Phase 2 clinical trial to evaluate the impact of a new dietary supplement, PhytoSERM, on menopausal hot flashes in women.Continue reading
Castle Bioscience CEO Interviewed on Behind the Bell
In this episode of Behind the Bell, Castle Biosciences Founder & CEO Derek J. Maetzold shares the impact of $CSTL being #NasdaqListed on the company’s mission in developing innovative genomic tests. Continue reading
NIA grant supports training of next generation of translational scientists for Alzheimer’s disease therapeutic development
Researchers at the Center for Innovation in Brain Science received a $1.4 million Translational Research in Alzheimer’s Disease and Related Dementias grant.Continue reading
GT Medical Technologies, Inc.’ GammaTile® Therapy Awarded 2023 Most Promising New Product of the Year by The Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers
Oct. 13, 2023 /PRNewswire/ — GT Medical Technologies, Inc. a medical device company dedicated to improving the lives of patients with brain tumors, today announced that its FDA-cleared GammaTile® Therapy was awarded the 2023 Most Promising New Product of the Year by The Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers. Continue reading